MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
Mukherjee, Nabanita, Skees, Jenette, Todd, Kaleb J., West, Drake A., Lambert, Karoline A., Robinson, William A., Amato, Carol M., Couts, Kasey L., Van Gulick, Robert, MacBeth, Morgan, Nassar, Kelsey, Tan, Aik-Choon, Zhai, Zili, Fujita, Mayumi, Bagby, Stacey M., Dart, Chiara R., Lambert, James R., Norris, David A., Shellman, Yiqun G.
Published in Cell death & disease (08.06.2020)
Published in Cell death & disease (08.06.2020)
Get full text
Journal Article
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
Mukherjee, Nabanita, Amato, Carol M, Skees, Jenette, Todd, Kaleb J, Lambert, Karoline A, Robinson, William A, Van Gulick, Robert, Weight, Ryan M, Dart, Chiara R, Tobin, Richard P, McCarter, Martin D, Fujita, Mayumi, Norris, David A, Shellman, Yiqun G
Published in Cancers (05.08.2020)
Published in Cancers (05.08.2020)
Get full text
Journal Article